Darren Gleeman

The historic federal shift reclassifying medical marijuana to Schedule III brings undeniable progress, offering long-awaited tax relief from Section 280E. Yet, despite the initial market excitement, rescheduling is not a cure-all for the industry’s deep-rooted liquidity crisis. Cash buyers remain scarce, transactions rely heavily on seller financing, and regulatory fragmentation persists. True competitive advantage in a mature market won’t come from waiting on Washington. It will come from corporate architecture. Here’s why some cannabis operators are looking past policy hype and leveraging independent buyouts to achieve the ultimate business goal: a tax-free exit.

Cannabis operators are clinging to a capital playbook that no longer works — waiting on reform, “sideline” investors, or a return to the equity markets of five years ago. But the drought isn’t cyclical; it’s structural. Between 280E, regulatory unpredictability, and a vanished exit path, traditional equity logic collapses. The result is “toxic hope” that delays restructuring and burns runway. The fix isn’t optimism. It’s architecture: structures designed to work under current law.

Employee Stock Ownership Plans (ESOPs) are changing the way cannabis companies think about equity. By turning workers into owners, ESOPs improve retention, create generational wealth, and align business growth with social justice goals.

Successful cannabis businesses are strategic, savvy, and clever. They have to be, don’t they? With harsh regulations like Internal Revenue Code (IRC) Section 280E,...